MedTrace Logo

Saline-Enhanced Radiofrequency (SERF) Catheter Ablation for the Treatment of Ventricular Tachycardia

NCT02994446 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2022-04-28

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the technical feasibility of the SERF Catheter and SERF Cardiac Ablation System to eliminate or control ventricular tachycardia (VT)

Conditions

  • Tachycardia, Ventricular

Interventions

DEVICE

Saline-Enhanced Radiofrequency Catheter and Ablation System

Ablation of ventricular tachycardia with a saline-enhanced radiofrequency ablation catheter

Sponsors & Collaborators

  • Thermedical, Inc.

    lead INDUSTRY

Principal Investigators

  • Douglas L. Packer, MD · Mayo Clinic

  • Atul Verma, MD · Southlake Regional Health Centre

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2021-04-21
Completion
2021-10-04

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02994446 on ClinicalTrials.gov